Maura, G.
1800  results:
Search for persons X
?
1

Persistence of apremilast in moderate‐to‐severe psoriasis: ..:

Sbidian, E. ; Billionnet, C. ; Weill, A...
British Journal of Dermatology.  182 (2019)  3 - p. 690-697 , 2019
 
?
3

Identification des maladies neurodégénératives dans les bas..:

Gallini, A. ; Moisan, F. ; Maura, G....
Revue d'Épidémiologie et de Santé Publique.  65 (2017)  - p. S183-S197 , 2017
 
?
5

In vitro cortical neuronal networks as a new high-sensitive..:

Martinoia, S. ; Bonzano, L. ; Chiappalone, M....
Biosensors and Bioelectronics.  20 (2005)  10 - p. 2071-2078 , 2005
 
?
6

Stabilizing action of polymeric plasticisers in PVC:

Maura, G. ; Rinaldi, G.
Macromolecular Symposia.  176 (2001)  1 - p. 39-48 , 2001
 
?
8

Different subtypes of alpha2-adrenoceptor mediate inhibitio..:

MAURA, G
Pharmacological Research.  26 (1992)  - p. 143 , 1992
 
?
9

Modulation of 5-hydroxytryptamine release by presynaptic in..:

Raiteri, M. ; Maura, G. ; Folghera, S....
Naunyn-Schmiedeberg's Archives of Pharmacology.  342 (1990)  5 - p. , 1990
 
?
 
?
11

Presynaptic regulation of acetylcholine release in the CNS:

RAITERI, M ; MARCHI, M ; MAURA, G.
Cell Biology International Reports.  13 (1989)  12 - p. 1109-1118 , 1989
 
?
 
?
13

Subtype of 5-HT1 receptor regulating 3H-acetylcholine relea..:

Maura, G. ; Ferlito, M. ; Fedele, E..
Pharmacological Research Communications.  20 (1988)  - p. 232 , 1988
 
?
14

Presynaptic D-2 dopamine receptor regulating endogenous glu..:

Maura, G. ; Giardi, A. ; Costa, C..
Pharmacological Research Communications.  20 (1988)  - p. 233 , 1988
 
?
 
1-15